Alaunos Therapeutics, Inc. — All Filings
1,005 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10SB12G
10SB12G/A
144
3
3/A
4
4/A
424B3
424B5
424B7
424B8
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DFRN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
REGDEX
S-1
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PRE 14A | PRE 14A | 0001193125-25-116509 | May 9, 2025 | Jul 3, 2025 |
| 10-K/A | 10-K/A | 0000950170-25-061207 | Apr 30, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-055903 | Apr 18, 2025 | Apr 15, 2025 |
| 4 | 4 | 0000950170-25-054436 | Apr 15, 2025 | Apr 11, 2025 |
| 8-K | 8-K | 0000950170-25-054309 | Apr 15, 2025 | — |
| 4 | 4 | 0000950170-25-054429 | Apr 15, 2025 | Apr 13, 2025 |
| 4 | 4 | 0000950170-25-054432 | Apr 15, 2025 | Apr 13, 2025 |
| 8-K | 8-K | 0000950170-25-053523 | Apr 14, 2025 | Apr 11, 2025 |
| 8-K | 8-K | 0000950170-25-053325 | Apr 11, 2025 | Apr 7, 2025 |
| 4 | 4 | 0000950170-25-048491 | Apr 1, 2025 | Mar 29, 2025 |
| 4 | 4 | 0000950170-25-048492 | Apr 1, 2025 | Mar 29, 2025 |
| 4 | 4 | 0000950170-25-048554 | Apr 1, 2025 | Mar 29, 2025 |
| 10-K | 10-K | 0000950170-25-047758 | Mar 31, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0000950170-25-019905 | Feb 13, 2025 | — |
| 4 | 4 | 0000950170-25-001257 | Jan 3, 2025 | Dec 31, 2024 |
| 144 | — | 0001959173-24-008881 | Dec 31, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-126793 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-258550 | Nov 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-113960 | Oct 10, 2024 | Oct 4, 2024 |
| 4 | 4 | 0000950170-24-098045 | Aug 16, 2024 | Aug 14, 2024 |
| 4 | 4 | 0000950170-24-098103 | Aug 16, 2024 | Aug 14, 2024 |
| 10-Q | 10-Q | 0000950170-24-097142 | Aug 14, 2024 | Jun 30, 2024 |
| 8-K/A | 8-K/A | 0000950170-24-084024 | Jul 17, 2024 | Jul 16, 2024 |
| 8-K/A | 8-K/A | 0000950170-24-084023 | Jul 17, 2024 | Jul 16, 2024 |
| 8-K | 8-K | 0000950170-24-083764 | Jul 16, 2024 | — |
| 8-K | 8-K | 0000950170-24-083765 | Jul 16, 2024 | — |
| 8-K | 8-K | 0000950170-24-076333 | Jun 21, 2024 | Jun 19, 2024 |
| 8-K | 8-K | 0000950170-24-072534 | Jun 12, 2024 | Jun 6, 2024 |
| 4 | 4 | 0000950170-24-071400 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | 4 | 0000950170-24-071401 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | 4 | 0000950170-24-071399 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | 4 | 0000950170-24-071396 | Jun 10, 2024 | Jun 6, 2024 |
| 10-Q | 10-Q | 0000950170-24-060075 | May 15, 2024 | Mar 31, 2024 |
| ARS | ARS | 0001193125-24-118282 | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | DEFA14A | 0001193125-24-118265 | Apr 26, 2024 | — |
| DEF 14A | DEF 14A | 0001193125-24-118247 | Apr 26, 2024 | Jun 6, 2024 |
| PRE 14A | PRE 14A | 0001193125-24-096391 | Apr 15, 2024 | Jun 6, 2024 |
| 10-K | 10-K | 0000950170-24-038868 | Apr 1, 2024 | Dec 31, 2023 |
| 3 | 3 | 0000950170-24-022569 | Feb 28, 2024 | Feb 22, 2024 |
| 8-K | 8-K | 0001193125-24-042903 | Feb 22, 2024 | Feb 15, 2024 |
| 8-K | — | 0001193805-24-000251 | Feb 20, 2024 | Feb 16, 2024 |
| SC 13G/A | — | 0000919574-24-001345 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-033902 | Feb 13, 2024 | — |
| 8-K | — | 0001193805-24-000111 | Feb 1, 2024 | Jan 31, 2024 |
| 8-K | — | 0001193805-24-000103 | Jan 29, 2024 | — |
| 4 | 4 | 0000950170-24-006700 | Jan 23, 2024 | Jan 20, 2024 |
| 8-K | 8-K | 0001193125-24-012201 | Jan 22, 2024 | Jan 20, 2024 |
| 3 | 3 | 0000950170-24-001161 | Jan 3, 2024 | Dec 29, 2023 |
| 4 | 4 | 0000950170-24-001195 | Jan 3, 2024 | Dec 29, 2023 |
| 8-K | 8-K | 0001193125-24-000240 | Jan 2, 2024 | Dec 29, 2023 |